Vor Biopharma Inc.
VOR
$0.5671
-$0.0229-3.88%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 46.36% | -26.91% | -20.04% | -21.65% | -14.32% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -0.02% | 3.86% | 5.61% | 21.50% | -14.16% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 33.33% | 4.78% | -46.35% | 6.74% | -28.79% |
Total Current Assets | 43.41% | -25.44% | -19.28% | -20.59% | -14.37% |
|
|||||
Total Current Assets | 43.41% | -25.44% | -19.28% | -20.59% | -14.37% |
Net Property, Plant & Equipment | -4.99% | -4.55% | -4.43% | -4.23% | -3.82% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -2.62% | -10.06% | -24.28% | 0.10% | 11.17% |
Total Assets | 23.19% | -18.08% | -15.23% | -15.70% | -11.16% |
|
|||||
Total Accounts Payable | 14.36% | -34.43% | -13.68% | 185.28% | -37.74% |
Total Accrued Expenses | 45.41% | 15.43% | 10.82% | -36.57% | 5.72% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 1.25% | 1.22% | 3.94% | 3.32% | 2.32% |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 29.75% | 3.94% | 4.45% | -15.15% | 1.20% |
|
|||||
Total Current Liabilities | 29.75% | 3.94% | 4.45% | -15.15% | 1.20% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -3.75% | -3.42% | -3.49% | -3.29% | -3.12% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 7.41% | -1.08% | -1.11% | -7.19% | -1.74% |
|
|||||
Common Stock & APIC | 10.91% | 0.46% | 0.58% | 0.64% | 0.41% |
Retained Earnings | -7.20% | -6.91% | -7.51% | -9.06% | -8.37% |
Treasury Stock & Other | -67.65% | 197.14% | 19.54% | -12.99% | 72.50% |
Total Common Equity | 32.50% | -25.62% | -20.28% | -18.37% | -13.76% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 32.50% | -25.62% | -20.28% | -18.37% | -13.76% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 32.50% | -25.62% | -20.28% | -18.37% | -13.76% |
|